Clearway Energy LLC filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-08. Between them they name 3 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Steven Ryder, Chief Financial Officer
In connection with Ms. Rubenstein's transition, Steven Ryder, the Executive Vice President and Chief Financial Officer of CEG, was appointed as Chief Financial Officer of the Company, effective as of the Transition Date.
Appointed: Samantha Prout, Senior Vice President, Accounting and Controller, effective 2026-09-08
Effective September 8, 2026, the Company appointed Samantha Prout as Senior Vice President, Accounting and Controller.
Departing: Kevin P. Malcarney, Executive Vice President, General Counsel and Corporate Secretary, effective 2026-06-01
On May 15, 2026, Clearway Energy, Inc. ("Clearway, Inc."), the parent company of Clearway Energy LLC (the "Company") announced that Kevin P. Malcarney will retire from his position as Executive Vice President, General Counsel and Corporate Secretary of the Company, effective June 1, 2026 (the "Transition Date").
Find people with the same kind of experience as the Chief Financial Officer at Clearway Energy LLC, with the record behind each one.
Find candidates like Chief Financial Officer at Clearway Energy LLCNew leaders review vendors and budgets in their first months. Get an alert the next time Clearway Energy LLC is in the news or changes leadership.
Get an alert when Clearway Energy LLC changes leadershipTools for this story
Each opens in a new tab, filled in for Clearway Energy LLC. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.